Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Rank in Stocks #17922
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Share Price
$18.20
Last synced: 2025-05-09
Market Cap
$220.35M
Change (1 day)
-5.34%
Change (1 year)
0.00%
Country
JP
Trade I'rom Group Co., Ltd. (2372)

Category

P/E ratio for I'rom Group Co., Ltd. (2372)
P/E ratio as of September 2026 TTM: 23.87
According to I'rom Group Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.87. At the end of 2023 the company had a P/E ratio of 9.00.
P/E ratio history for I'rom Group Co., Ltd. from 2005 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 23.87 51.38%
2024 15.77 75.19%
2023 9.00 -24.11%
2022 11.86 -44.55%
2021 21.39 73.82%
2020 12.31 -37.15%
2019 19.58 -13.70%
2018 22.69 -68.97%
2017 73.11 -609.38%
2016 -14.35 -51.65%
2015 -29.69 20.45%
2014 -24.65 -927.07%
2013 2.98 -143.04%
2012 -6.92 -180.91%
2011 8.56 -415.97%
2010 -2.71 876.98%
2009 -0.28 -96.70%
2008 -8.40 -64.84%
2007 -23.89 -116.95%
2006 140.94 40.24%
2005 100.50 0.00%
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.